Identifying Oversold Stocks in Health Care: Opportunities Await

Investors often find an opportunity when they come across oversold stocks in the health care sector. These are shares that may be undervalued and could present a good buying chance.

The Relative Strength Index (RSI) serves as a momentum indicator, showing how a stock performs on days it goes up compared to when it goes down. If a stock’s RSI is below 30, it is generally considered oversold, as noted by Benzinga Pro. This can provide vital insights for traders about short-term performance.

The following companies show significant oversold indicators in the current market.

Revolution Medicines Inc RVMD

• On Dec. 3, Revolution Medicines completed a public offering, raising $750 million by pricing 14,130,436 shares at $46 each. The stock fell roughly 17% in the last five days and touched a 52-week low of $23.38.
• RSI Value: 27.88
• RVMD Price Action: The stock closed down 6.9% at $48.23 on Tuesday.
• Benzinga Pro’s live news alerts provided updates on RVMD’s recent developments.

Elanco Animal Health Inc ELAN           

• On Dec. 2, Daniel Clark from Leerink Partners began coverage on Elanco Animal Health, giving it a Market Perform rating and setting a price target of $14. The stock experienced a 7% decline over the previous five days, reaching a 52-week low of $11.40.
• RSI Value: 27.85
• ELAN Price Action: The stock closed at $12.48 after falling 7.4% on Tuesday.
• Benzinga Pro’s charting tool highlighted the recent trends in ELAN’s performance.

Sotera Health Co SHC

• On Nov. 5, Sotera Health reported quarterly earnings of 17 cents per share, falling short of the analyst consensus estimate of 18 cents. However, the company’s sales reached $285.468 million, surpassing expectations of $278.585 million. According to Michael B. Petras, Jr., Chairman and CEO, the results met expectations, with additional revenue from cobalt-60 shipments. The stock has declined about 19% in the past month and hit a 52-week low of $10.71.
• RSI Value: 29.58
• SHC Price Action: Shares closed at $12.83, down 3.2% on Tuesday.
• Benzinga Pro’s signals feature indicated a potential breakout for SHC shares.

Read More: